The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever

Abstract

Background

Both C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) can be elevated in systemic lupus erythematosus (SLE) flare and infection, and are therefore of limited utility for distinguishing between the two conditions in febrile SLE patients.

Methods

A medical records review of hospitalizations (1997–2006) of SLE patients in the Michigan Lupus Cohort was performed. Eligible hospitalizations were those in which patients presented with a temperature of >100.3°F or with subjective fevers as a presenting complaint at admission. Detailed demographic, clinical, and laboratory data were collected. Multivariable logistic regression was used to examine the associations between ESR and CRP and the outcome of flare vs infection, adjusted for confounders.

Results

Among 557 SLE patients screened, there were 53 eligible hospitalizations (28 flares and 25 infections). Each unit increase in the ratio of ESR:CRP was associated with a 17% increase in the odds of fever being attributable to SLE flare compared to infection (OR 1.17, 95% CI 1.04, 1.31; p = 0.009), when adjusted for white blood cell count, SLE duration, sex, race, and age. ESR and CRP were not individually associated with flare vs infection when modeled with their ratio.

Conclusions

The ratio of ESR:CRP may provide diagnostic value beyond individual ESR and CRP levels in distinguishing flare vs infection in SLE patients presenting with fever.

Keywords

Biomarkers inflammation systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Keenan

Swearingen

Yazici

. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clin Exp Rheumatol 2008; 26: 814–819.

Becker

Waldburger

Hughes

Pepys

. Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 1980; 39: 50–52.

Vilá

Alarcón

McGwin

Jr Bastian

Fessler

Reveille

. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 2005; 32: 2150–2155.

Bertouch

Roberts-Thompson

Feng

Bradley

. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus. Ann Rheum Dis 1983; 42: 655–658.

ter Borg

Horst

Limburg

van Rijswijk

Kallenberg

. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol 1990; 17: 1642–1648.

Vanderschueren

Deeren

Knockaert

Bobbaers

Bossuyt

Peetermans

. Extremely elevated C-reactive protein. Eur J Intern Med 2006; 17: 430–433.

Morley

Kushner

. Serum C-reactive protein levels in disease. Ann N Y Acad Sci 1982; 389: 406–418.

Honig

Gorevic

Weissmann

. C-reactive protein in systemic lupus erythematosus. Arthritis Rheum 1977; 20: 1065–1070.

Bravo

Alarcón-Segovia

. C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE. J Rheumatol 1981; 8: 291–294.

10.

Firooz

Albert

Wallace

Ishimori

Berel

Weisman

. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 2011; 20: 588–597.

11.

Tan

Cohen

Fries

et al.

The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

12.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

13.

Fors Nieves

Cronstrin

Saxena

Kelley and Firestein's Textbook of Rheumatology. In: Firestein

Budd

Gabriel

McInnes

O’Dell

(eds). Kelley and Firestein’s textbook of rheumatology, 10th ed. Philadelphia: Elsevier, 2016, pp. 846–853.

14.

Gaitonde

Samols

Kushner

. C-reactive protein and systemic lupus erythematosus. Arthritis Rheum 2008; 59: 1814–1820.

15.

O’Neill

Giles

Lambrianides

et al.

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2010; 62: 845–854.

16.

Sjöwall

Zickert

Skogh

Wetterö

Gunnarsson

. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Res Ther 2009; 11: R188–R188.

17.

Thacker

Berthier

Mattinzoli

Rastaldi

Kretzler

Kaplan

. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: Potential role in atherogenesis and renal vascular rarefaction. J Immunol 2010; 185: 4457–4469.

18.

Denny

Yalavarthi

Zhao

et al.

A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010; 184: 3284–3297.

19.

Enocsson

Sjöwall

Skogh

Eloranta

Rönnblom

Wetterö

. Interferon-alpha mediates suppression of C-reactive protein: Explanation for muted C-reactive protein response in lupus flares? Arthritis Rheum 2009; 60: 3755–3760.

20.

Haran

Beaudoin

Suner

. C-reactive protein as predictor of bacterial infection among patients with an influenza-like illness. Am J Emerg Med 2012; 2011: 137–144.

21.

Peltola

Jaakkola

. C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children. J Pediatr 1988; 113: 641–646.

22.

Tejani

Chonmaitree

Rassin

Howie

Owen

Goldman

. Use of C-reactive protein in differentiation between acute bacterial and viral otitis media. Pediatrics 1995; 95: 664–669.

23.

Brigden

. The erythrocyte sedimentation rate. Still a helpful test when used judiciously. Postgrad Med 1998; 103: 257–262, 272–274.

24.

Ridker

Cannon

Morrow

et al.

C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20–28.

25.

Barnes

Narain

Naranjo

et al.

High sensitivity C-reactive protein in systemic lupus erythematosus: Relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus 2005; 14: 576–582.

26.

Lee

Singh

Link

Petri

. High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum 2011; 4: 41–54.

27.

Swaak

van Rooyen

Aarden

. Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int 1989; 8: 263–268.

28.

Mochizuki

Aotsuka

Satoh

. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med 1999; 93: 95–101.